HA-REACT: Joint Action on HIV and Co-Infection Prevention and Harm Reduction

The Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) addresses existing gaps in the prevention of HIV and other co-infections, especially tuberculosis (TB) and viral hepatitis, among people who inject drugs (PWID). This three-year project was launched in late 2015 with core funding  from the European Union (EU), and is being implemented by 23  partners in 18 EU Member States. Twelve collaborating partners are contributing additional expertise, among them the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

HA-REACT MAIN OBJECTIVES

  • To significantly contribute to the elimination of HIV and to reductions in cases of TB and viral hepatitis among PWID in the European Union by 2020. This objective is aligned with strategic action plans issued by the European Union, the World Health Organization, UNAIDS and the United Nations Office on Drugs and Crime.
  • To focus particularly on Member States where there are obvious gaps in effective and evidence-informed interventions, or where such interventions are not being implemented at a sufficient level.
  • To encourage the implementation of comprehensive harm reduction programmes at sufficient scale in all EU Member States as an essential strategy for improving the prevention and treatment of HIV, TB and viral hepatitis.

Find out more abot this Joint Action at hareact.eu

Contact person: 
Oksana Panochenko
Address: 
Germany
Lead Partner: 
Mika Salminen (leader) and Outi Karvonen (project manager), National Institute for Health and Welfare, Finland
Associated Partners: 
Croatia. Croatian Institute of Public Health (Hrvatski Zavod Za Javno Zdravstvo) Croatia. Life Quality Improvement Organisation - NGO FLIGHT (Udruga Za Unapredenje Kvalitete Zivljenja) Czech Republic. National Monitoring Centre for Drugs and Addiction (Urad Vlady Ceske Republiky) Denmark. Centre for Health and Infectious Disease Research, Rigshospitalet, University of Copenhagen Estonia. National Institute for Health Development (Tervise Arengu Instituut) Greece. Hellenic Center for Disease Control Αnd Prevention (Kentro Eleghou & Prolipsis Nosimaton) Germany. Center of Interdisciplinary Addiction Research (Zentrum fur interdisziplinare Suchtforschung der Universitaet Hamburg) Germany. Institut fur Suchtforschung Germany. Deutsche AIDS-Hilfe Germany. AIDS Action Europe Hungary. National Centre for Epidemiology (Országos Epidemiológiai Központ) Hungary. Office of the Chief Medical Officer (Országos Tisztifőorvosi Hivatal) Iceland. Landspitali University Hospital Italy. National Institute for Infectious Diseases (Istituto Nazionale Malattie Infettive L. Spallanzani) Latvia. Center For Disease Prevention and Control (Slimibu Profilakses Un Kontroles Centrs) Lithuania. Centre for Communicable Diseases and AIDS (Uzkreciamuju Ligu Ir Aids Centras) Lithuania. Vilnius Centre for Addictive Disorders (Vilniaus Priklausomybes Ligu Centras) Luxembourg. Directorate of Health – Division of Sanitary Inspection (Ministere De La Sante) Malta. Ministry for Health Poland. National AIDS Centre (Krajowe Centrum ds. AIDS) Portugal. Directorate-General of Health (Ministerio Da Saude) Slovenia. Association SKUC (Drustvo Studentski Kulturni Center) Spain. Instituto de Salud Carlos III, Biomedical Research Networking Centres (CIBER)
Project objectives: 
To significantly contribute to the elimination of HIV and to reductions in cases of TB and viral hepatitis among PWID in the European Union by 2020. This objective is aligned with strategic action plans issued by the European Union, the World Health Organization, UNAIDS and the United Nations Office on Drugs and Crime. To focus particularly on Member States where there are obvious gaps in effective and evidence-informed interventions, or where such interventions are not being implemented at a sufficient level. To encourage the implementation of comprehensive harm reduction programmes at sufficient scale in all EU Member States as an essential strategy for improving the prevention and treatment of HIV, TB and viral hepatitis.
Collaborating Partners: 
Coordinadora Estatal de VIH-SIDA, Spain Czech AIDS Help Society Department of Health, London, United Kingdom European Centre for Disease Prevention and Control European Monitoring Centre for Drugs and Drug Addiction Free Clinic, Belgium Medical and Public Health Services of the Ministry of Health of the Republic of Cyprus Ministry of Health, Czech Republic National Institute of Public Health, Czech Republic Norwegian Institute of Public Health Public Health Agency of Sweden Vilnius University, Lithuania
Duration of Project: 
October 2015 - September 2018
Output / Materials produced: 
ongoing
Dissemination Channels: 
Via mailing, social media (#HAREACT), website, presentations and other online and offline media.
English
EU Project: 
EU Project

Twitter News

Sign up for our Newsletter